secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ingevity Corp (NGVT)
CIK:        0001653477
Form:       8-K
Filed at:   2025-01-16T23:59:59+00:00
Accession:  0001653477-25-000005
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ingevity explores sale of Industrial Specialties line; prelim FY2024 sales $1.40B, EBITDA ~$360M
--------------------------------------------------------------------------------

- Exploring strategic alternatives for Performance Chemicals Industrial Specialties product line, including potential divestiture of North Charleston CTO refinery.
- Preliminary FY2024 net sales ~$1.40B; Adjusted EBITDA ~$360M (high end of prior guidance); free cash flow >$40M (significantly above guidance).
- 2025 Adjusted EBITDA expected slightly above $400M, excluding any impact from strategic alternatives review.
- Management evaluating additional actions to maximize shareholder value; sequential segment EBITDA margin improvement in H2 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1653477/000165347725000005/0001653477-25-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1653477/000165347725000005/ngvt-20250116.htm
  HTML page:      https://secwatch.observer/filing/0001653477-25-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer